EFDID: 361516EFD: View Filing

Issuer: Enveric Biosciences, Inc. (0000890821) - D

Accession: 0001493152-21-001407 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000890821
  • Entity Name:
    Enveric Biosciences, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    4851 TAMIAMI TRAIL N
    SUITE 200
    NAPLES, FL 34103
  • Persons:
    Related Persons 6
    John Van Buiten
    Executive Officer 
    Chief Financial Officer
    David Johnson
    Executive Officer, Director 
    Chief Executive Officer and Chairman
    Avani Kanubaddi
    Executive Officer 
    Chief Operations Officer
    George Kegler
    Director
    Sol Mayer
    Director
    Marcus Schabacker
    Director
EDGAR: Offering Information
  • Accession Date:
    01/20/2021
  • First Sale Date:
    01/12/2021
  • Offering Amount:
    $8,249,959
  • Amount Sold:
    $0
  • Amount Remaining:
    $8,249,959
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    Represents warrants to purchase up to 1,666,019 shares of common stock at an exercise price of $4.9519 per share.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Enveric Biosciences, Inc./s/ John Van BuitenJohn Van BuitenChief Financial Officer2021-01-20